10 January 2012 :

The blog "The Pentobarbital Experiment" summarized, with very polemical tone, the role of the Danish company "Lundbeck" in the 2011 executions in the U.S..
“A very interesting A.P. release from December 21, 2011 did not make the headlines. We learn that Lundbeck is selling the Pentobarbital rights.
“Lundbeck says pentobarbital, also known by its trademark name, Nembutal, was never an important part of its business.” You bet! So unimportant that Lundbeck ignored the deadly outcome of the use of pentobarbital in human executions in the US. Pentobarbital is now the property of Akorn, welcome to the death club! 36 dead patients later (yes Lundbeck is always first so it already killed its 1st patient in 2012), the politically-correct solution appears to be getting read of the brand altogether. [… ] Don’t kid yourself Mr. Wiinberg, your criminal negligence will follow you, no matter what you attempt to erase the collective memory of the only contemporary death lab in Europe.
No doubt that Lundbeck’s shareholders are going to be very impressed by this latest act of cowardice and they should be encouraged to sell their shares and protest this murderous mishap.
So now, Mr. Ulf Wiinberg, Lundbeck’s CEO, is coming to California to promote his death lab. He will be attending the 30th Annual J. P. Morgan Healthcare Conference in San Francisco on January 9th at 8:00am. We urge all activists in the Bay Area to attend Mr. Wiinberg’s presentation and to challenge his lack of ethics that killed 36 to date. [… ]
The Lundbeck problem is far from over as stocks of Pentobarbital have been acquired by a number of states in order to continue their barbaric killing practice.”